Claudia Sedlinsky

903 total citations
17 papers, 736 citations indexed

About

Claudia Sedlinsky is a scholar working on Molecular Biology, Oncology and Clinical Biochemistry. According to data from OpenAlex, Claudia Sedlinsky has authored 17 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Clinical Biochemistry. Recurrent topics in Claudia Sedlinsky's work include Metabolism, Diabetes, and Cancer (10 papers), Bone Metabolism and Diseases (5 papers) and Advanced Glycation End Products research (4 papers). Claudia Sedlinsky is often cited by papers focused on Metabolism, Diabetes, and Cancer (10 papers), Bone Metabolism and Diseases (5 papers) and Advanced Glycation End Products research (4 papers). Claudia Sedlinsky collaborates with scholars based in Argentina, United States and Spain. Claudia Sedlinsky's co-authors include Antonio Desmond McCarthy, Ana Marı́a Cortizo, León Schurman, María Silvina Molinuevo, María José Tolosa, Verónica Arnol, María Virginia Gangoiti, Liliana Bruzzone, María L. Sbaraglini and Sara Chuguransky and has published in prestigious journals such as Journal of Bone and Mineral Research, European Journal of Pharmacology and Molecular and Cellular Endocrinology.

In The Last Decade

Claudia Sedlinsky

15 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Sedlinsky Argentina 10 481 251 239 135 99 17 736
León Schurman Argentina 12 475 1.0× 247 1.0× 253 1.1× 158 1.2× 102 1.0× 22 824
Yasuyuki Katayama Japan 15 268 0.6× 244 1.0× 163 0.7× 138 1.0× 65 0.7× 24 684
T. Sugimoto Japan 10 199 0.4× 140 0.6× 163 0.7× 66 0.5× 75 0.8× 18 436
Verónica Arnol Argentina 4 210 0.4× 109 0.4× 111 0.5× 56 0.4× 44 0.4× 5 338
Hannele Ylipahkala Finland 8 414 0.9× 302 1.2× 254 1.1× 64 0.5× 60 0.6× 10 729
Fumitoshi Ohori Japan 14 560 1.2× 217 0.9× 165 0.7× 44 0.3× 66 0.7× 35 894
Yasuhiko Nara Japan 13 494 1.0× 187 0.7× 152 0.6× 32 0.2× 62 0.6× 23 798
Sílvia Ruiz-Gaspà Spain 17 300 0.6× 204 0.8× 210 0.9× 42 0.3× 164 1.7× 29 694
Masaaki Shima Japan 14 164 0.3× 98 0.4× 83 0.3× 136 1.0× 35 0.4× 22 542
Gen Kuroyanagi Japan 14 335 0.7× 105 0.4× 139 0.6× 32 0.2× 155 1.6× 90 695

Countries citing papers authored by Claudia Sedlinsky

Since Specialization
Citations

This map shows the geographic impact of Claudia Sedlinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Sedlinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Sedlinsky more than expected).

Fields of papers citing papers by Claudia Sedlinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Sedlinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Sedlinsky. The network helps show where Claudia Sedlinsky may publish in the future.

Co-authorship network of co-authors of Claudia Sedlinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Sedlinsky. A scholar is included among the top collaborators of Claudia Sedlinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Sedlinsky. Claudia Sedlinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sedlinsky, Claudia, et al.. (2025). Metformin reverts aortic calcifications and elastin loss induced by an experimental metabolic syndrome. Endocrine Connections. 14(2).
2.
Sedlinsky, Claudia, et al.. (2024). Tratamiento con metformina previene la adiposidad de la médula ósea femoral inducida por un síndrome metabólico experimental en ratas. Revista Peruana de Medicina Experimental y Salud Pública. 41(1). 28–36. 1 indexed citations
3.
Molinuevo, María Silvina, Ana Marı́a Cortizo, & Claudia Sedlinsky. (2023). Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies. Journal of Diabetes and its Complications. 37(11). 108626–108626. 3 indexed citations
4.
Meroño, Tomás, et al.. (2021). Incidence and predictive factors of postoperative hypocalcaemia according to type of thyroid surgery in older adults. Endocrine. 75(1). 276–283. 5 indexed citations
5.
Schurman, León, A.M. Galich, Claudio González, et al.. (2017). [Argentine guidelines for the diagnosis, prevention and treatment of osteoporosis, 2015].. PubMed. 77(1). 46–60. 7 indexed citations
6.
Molinuevo, María Silvina, Juan Manuel Fernández, Ana Marı́a Cortizo, et al.. (2017). Advanced glycation end products and strontium ranelate promote osteogenic differentiation of vascular smooth muscle cells in vitro: Preventive role of vitamin D. Molecular and Cellular Endocrinology. 450. 94–104. 22 indexed citations
7.
Schurman, León, et al.. (2017). Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment. Diabetes Research and Clinical Practice. 126. 202–213. 24 indexed citations
8.
McCarthy, Antonio Desmond, Ana Marı́a Cortizo, & Claudia Sedlinsky. (2016). Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy. World Journal of Diabetes. 7(6). 122–122. 44 indexed citations
9.
Sbaraglini, María L., María Silvina Molinuevo, Claudia Sedlinsky, León Schurman, & Antonio Desmond McCarthy. (2014). Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells. European Journal of Pharmacology. 727. 8–14. 25 indexed citations
10.
Tolosa, María José, Sara Chuguransky, Claudia Sedlinsky, et al.. (2013). Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin. Diabetes Research and Clinical Practice. 101(2). 177–186. 53 indexed citations
11.
Fernández, Juan Manuel, María Silvina Molinuevo, Claudia Sedlinsky, et al.. (2013). Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation. European Journal of Pharmacology. 706(1-3). 41–47. 20 indexed citations
12.
Tolosa, María José, Sara Chuguransky, León Schurman, et al.. (2012). La diabetes altera el potencial osteogénico de células progenitoras de médula ósea: Efectos del tratamiento con metformina. CIC-Digital (Comisión de Investigaciones Científicas de la Provincia de Buenos Aires). 49(2). 0–0. 1 indexed citations
13.
Sedlinsky, Claudia, María Silvina Molinuevo, Ana Marı́a Cortizo, et al.. (2011). Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats. European Journal of Pharmacology. 668(3). 477–485. 52 indexed citations
14.
Molinuevo, María Silvina, León Schurman, Antonio Desmond McCarthy, et al.. (2009). Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies. Journal of Bone and Mineral Research. 25(2). 211–221. 188 indexed citations
15.
Schurman, León, Antonio Desmond McCarthy, Claudia Sedlinsky, et al.. (2008). Metformin Reverts Deleterious Effects of Advanced Glycation End-Products (AGEs) on Osteoblastic Cells. Experimental and Clinical Endocrinology & Diabetes. 116(6). 333–340. 81 indexed citations
16.
Cortizo, Ana Marı́a, et al.. (2006). Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. European Journal of Pharmacology. 536(1-2). 38–46. 201 indexed citations
17.
Schurman, León, Claudia Sedlinsky, Andrea Mangano, et al.. (2001). Estrogenic status influences nitric oxide-regulated TNF-α release from human peripheral blood monocytes. Experimental and Clinical Endocrinology & Diabetes. 109(6). 340–344. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by León Schurman Breakdown of academic impact, for papers by Yasuyuki Katayama Breakdown of academic impact, for papers by T. Sugimoto Breakdown of academic impact, for papers by Verónica Arnol Breakdown of academic impact, for papers by Hannele Ylipahkala Breakdown of academic impact, for papers by Fumitoshi Ohori Breakdown of academic impact, for papers by Yasuhiko Nara Breakdown of academic impact, for papers by Sílvia Ruiz-Gaspà Breakdown of academic impact, for papers by Masaaki Shima Breakdown of academic impact, for papers by Gen Kuroyanagi
Rankless by CCL
2026